AKT1 and cancer: Metformin decreased the levels of insulin and IGF-1, and thereby inhibited phosphorylation of insulin receptor substrate-1/2 (IRS-1/2) and PI3K/AKT/mTOR signaling, which plays a key role in controlling aging and cancer 7, 112.